Indications
Umactin is specifically indicated for the treatment & prophylaxis of urinary tract infections caused by susceptible strains of Escherichia coli, Enterococci, Staphylococcus aureus, Staphylococcus saprophyticus and certain susceptible strains of Klebsiella and Enterobacter species.
Pharmacology
Nitrofurantoin is an antibacterial agent specific for urinary tract infections. Nitrofurantoin is highly soluble in urine, to which it may impart a brown color. Nitrofurantoin inactivates or alters bacterial ribosomal proteins and other macromolecules. Nitrofurantoin has been shown to be active against the following bacteria: Gram-Positive Aerobes Staphylococcus saprophyticus, Coagulase-negative staphylococci (including Staphylococcus epidermidis), Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae, Group D streptococci, Viridans group streptococci. Gram-Negative Aerobes- Escherichia coli, Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Klebsiella oxytoca, Klebsiella ozaenae.
Dosage and administration
Nitrofurantoin tablet (In adults):
Uncomplicated urinary tract infections : 50-100 mg four times a day- the lower dosage level is recommended. Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained.
For long-term suppressive therapy : In adults, a reduction of dosage to 50-100 mg at bedtime may be adequate.
Nitrofurantoin capsule (In adults):
Acute Uncomplicated Urinary Tract Infections (UTIs) : 50 mg four times daily for 7 days.
Long term suppression : 50-100 mg once a day.
Prophylaxis : 50 mg four times daily for the duration of procedure and for three days thereafter.
Nitrofurantoin SR capsule:
Adults and Children over 12 years : One 100 mg capsule every 12 hours for seven days.
Genito-urinary surgical prophylaxis : One capsule twice daily on day of procedure and for next 3 days.
Nitrofurantoin suspension: Children: 5-7 mg/kg/day in four divided doses (contraindicated under one month of age). The average dose of Nintoin suspension for pediatric patients are as follows-
7 to 11 kg: ½ (2.5 ml) teaspoonfuls 4 times daily.
12 to 21 kg: 1 (5 ml) teaspoonfuls 4 times daily.
22 to 30 kg: 1½ (7.5 ml) teaspoonfuls 4 times daily.
31 to 41 kg: 2 (10 ml) teaspoonfuls 4 times daily.
Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained. For long-term suppressive therapy in children, doses as low as 1 mg/kg per 24 hours, given in a single dose or in two divided doses, may be adequate.
Interactions
Antacids containing Magnesium Trisilicate, when administered concomitantly with Umactin, reduce both the rate and extent of absorption of Uricosuric drugs, such as Probenecid and Sulfinpyrazone, can inhibit renal tubular secretion of Umactin.
Contraindications
Anuria, oliguria or significant impairment of renal function are contraindications. This drug is contraindicated in pregnant patients at 38-42 weeks, during labor and delivery. Nitrofurantoin is also contraindicated in those patients with known hypersensitivity to Nitrofurantoin.
Side effects
The most frequent clinical adverse events are nausea, headache, and flatulence. Other less occurred adverse events are diarrhea, dyspepsia, abdominal pain, constipation, emesis, dizziness and drowsiness.
Pregnancy and lactation
Pregnancy Category B. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Nitrofurantoin has been detected in human breast milk in trace amounts. Because of the potential for serious adverse reactions from Nitrofurantoin in nursing infants under one month of age, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Precautions and warnings
If acute, sub-acute or chronic pulmonary reactions occur, Umactin should be discontinued. Antacid preparations containing magnesium trisilicate should not be taken while taking Umactin.
Overdose
Occasional incidents of acute overdosage of Umactin have not resulted in any specific symptoms other than vomiting. Induction of emesis is recommended.
Storage
Do not store above 30°C. Keep away from light and out of the reach of children.
Similar brands of Nitrofurantoin
| # | Brand | Company | Form | Strength | Price |
|---|---|---|---|---|---|
| 1 | Uritro | Team Pharmaceuticals Ltd. | Capsule (Sustained Release) | 50 mg | ৳ 4.00per unit |
| 2 | Nintoin | Incepta Pharmaceuticals Ltd. | Capsule | 50 mg | ৳ 4.00per unit |
| 3 | Nitrofur SR | ACI Limited | Capsule (Sustained Release) | 50 mg | ৳ 4.00per unit |
| 4 | Euronit | Euro Pharma Ltd. | Tablet | 100 mg | ৳ 5.00per unit |
| 5 | Rantoin | Drug International Ltd. | Tablet | 100 mg | ৳ 6.00per unit |
| 6 | Urobak | Opsonin Pharma Ltd. | Tablet | 100 mg | ৳ 6.02per unit |
| 7 | Nintoin | Incepta Pharmaceuticals Ltd. | Tablet | 100 mg | ৳ 6.80per unit |
| 8 | Umactin | UniMed UniHealth Pharmaceuticals Ltd. | Capsule | 100 mg | ৳ 8.00per unit |
| 9 | Utifin SR | Aristopharma Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 10 | Uritro | Team Pharmaceuticals Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 11 | Nitrobac | The IBN SINA Pharmaceutical PLC | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 12 | Urobak SR | Opsonin Pharma Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 13 | NFT | Healthcare Pharmaceuticals Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 14 | Furabac | Popular Pharmaceuticals Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 15 | Euronit SR | Euro Pharma Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 20.00per unit |
| 16 | Urocure SR | Square Pharmaceuticals PLC | Capsule (Sustained Release) | 100 mg | ৳ 20.06per unit |
| 17 | Nintoin SR | Incepta Pharmaceuticals Ltd. | Capsule (Sustained Release) | 100 mg | ৳ 23.00per unit |
| 18 | Nitrofur SR | ACI Limited | Capsule (Sustained Release) | 100 mg | ৳ 26.00per unit |
| 19 | Ofuran SR | Pacific Pharmaceuticals Ltd. | Tablet (Sustained Release) | 100 mg | ৳ 26.00per unit |
| 20 | Urobak | Opsonin Pharma Ltd. | Oral Suspension | 25 mg/5 ml | Not listed |
| 21 | NFT | Healthcare Pharmaceuticals Ltd. | Oral Suspension | 25 mg/5 ml | Not listed |
| 22 | Uritro | Team Pharmaceuticals Ltd. | Oral Suspension | 25 mg/5 ml | Not listed |
| 23 | Nitrobac | The IBN SINA Pharmaceutical PLC | Oral Suspension | 25 mg/5 ml | Not listed |
| 24 | Umactin | UniMed UniHealth Pharmaceuticals Ltd. | Oral Suspension | 25 mg/5 ml | Not listed |
| 25 | Nitrofur | ACI Limited | Oral Suspension | 25 mg/5 ml | Not listed |
| 26 | Urocure | Square Pharmaceuticals PLC | Oral Suspension | 25 mg/5 ml | Not listed |
| 27 | Nintoin | Incepta Pharmaceuticals Ltd. | Oral Suspension | 25 mg/5 ml | Not listed |
Common questions
What is Umactin used for?
Umactin is specifically indicated for the treatment & prophylaxis of urinary tract infections caused by susceptible strains of Escherichia coli, Enterococci, Staphylococcus aureus, Staphylococcus saprophyticus and certain susceptible strains of Klebsiella and Enterobacter species.
What is the generic name of Umactin?
Umactin contains Nitrofurantoin, which belongs to the group: Systemic Urinary Anti- infective.
Who makes Umactin?
Umactin is marketed in Bangladesh by UniMed UniHealth Pharmaceuticals Ltd..
How much does Umactin 50 mg cost?
The listed price is ৳ 4.00 per unit and ৳ 40.00 per strip. Prices can change, so check with your pharmacy.
How is Umactin taken?
Nitrofurantoin tablet (In adults): Uncomplicated urinary tract infections : 50-100 mg four times a day- the lower dosage level is recommended. Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained. Always follow your doctor's instructions.
What are the side effects of Umactin?
The most frequent clinical adverse events are nausea, headache, and flatulence. Other less occurred adverse events are diarrhea, dyspepsia, abdominal pain, constipation, emesis, dizziness and drowsiness.
Is Umactin safe in pregnancy?
Pregnancy Category B. There are no adequate and well-controlled studies in pregnant women. Ask your doctor before using it while pregnant or breastfeeding.
This page is general information and is not medical advice. It does not replace a registered doctor, and it is not a prescription or a recommendation to use any medicine or test. Prices are listed prices and may change. Always follow the advice of your doctor or pharmacist.